10-HYDROXYCAMPTOTHECIN for Hepatocellular carcinoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 12 adverse event reports in the FDA FAERS database where 10-HYDROXYCAMPTOTHECIN was used for Hepatocellular carcinoma.
Most Reported Side Effects for 10-HYDROXYCAMPTOTHECIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Device use issue | 20 | 60.6% | 4 | 0 |
| Off label use | 20 | 60.6% | 4 | 0 |
| Post embolisation syndrome | 20 | 60.6% | 4 | 0 |
Other Indications for 10-HYDROXYCAMPTOTHECIN
Other Drugs Used for Hepatocellular carcinoma
ATEZOLIZUMAB (8,443)
BEVACIZUMAB (7,773)
LENVATINIB (5,384)
SORAFENIB (4,986)
CABOZANTINIB S-MALATE (2,670)
DURVALUMAB (1,255)
NIVOLUMAB (1,142)
REGORAFENIB (1,050)
TREMELIMUMAB\TREMELIMUMAB-ACTL (589)
PEMBROLIZUMAB (518)